Silence Therapeutics reported $93K in Loan Capital for its fiscal quarter ending in March of 2024.





Loan Capital Change Date
AstraZeneca USD 26.01B 46M Jun/2026
Autolus Therapeutics Ltd USD 277.27M 7.07M Mar/2026
Hikma Pharmaceutical USD 1.49B 692M Dec/2025
Novartis USD 37.49B 42M Jun/2026
Roche Holding CHF 25.22B 2.21B Jun/2026
Silence Therapeutics USD 93K 0 Mar/2024